Egrifta (tesamorelin)

pCPA File Number: 20831
Negotiation Status:
Negotiations were not pursued
Indication(s):
Lipodystrophy, HIV-infected patients
Sponsor/Manufacturer:
Theratechnologies Inc.
CDA-AMC Project Number:
SR0477-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: